BUZZ-Citi ups PT for Australia's Sigma Healthcare after regulator approves merger with Chemist Warehouse

Reuters
08 Nov 2024

** Analysts at Citi raise PT for Sigma Healthcare to A$2.50 from A$1.40; maintain "Neutral" rating

** Wholesale pharmaceuticals distributor SIG received on Thursday Australian competition watchdog's approval for an A$8.8 bln ($5.87 bln) merger with private firm Chemist Warehouse

** Brokerage says the upgraded PT reflects Chemist Warehouse's potential in the combined Sigma Chemist Warehouse Group

** Brokerage expects the combined group to generate EBIT of ~A$800 mln in FY26, its first full year

** "The combined group should continue to perform well in the prevailing high cost of living environment" - Citi

** "The network continues to grow in Australia and there are prospects for further international expansion" - Citi

** Stock has more than doubled in value this year, as of last close

($1 = 1.4997 Australian dollars)

(Reporting by Sherin Sunny in Bengaluru)

((Sherin.Sunny@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10